News and Announcements
First Two Patients in Clinical Trial for Canine Cancer Begin Treatment
- Published October 23, 2014 9:36AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
ASX Release – Wednesday 22nd October 2014
PharmAust Limited (ASX:PAA & PAAO) is pleased to announce that it has now initiated its trial of PPL-1 in dogs for the treatment of canine cancers. Within the last week, two dogs have begun treatment with PPL-1 formulated in “soft-gel” capsules to determine the safety and efficacy of PPL-1 in various canine cancers.
Dr Angela Frim berger of the Animal Referral Hospital (ARH) in Homebuss, NSW and Principal Investigator in the trial said,” The palatability issues of PPL-1 in dogs have largely been resolved by reformulation of PPL-1 into a tasteless, soft gel capsule making administration to pets by their owners far more practicable. Following our call for accrual of canine patients, we are seeing good progress in patient recruitment.”
To view the full ASX release, please click here.
Company Updates
Built on discipline, not complexity: inside an ASX equities income strategy
Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
Backed By Leading Investment Groups and Family Offices
